Clinical trial
Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous…
NCT00093132 · Agennix, Industry · Terminated
Key facts
| NCT number | NCT00093132 |
|---|---|
| Title | Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy |
| Official title | A Phase 1/2 Study With Satraplatin and Simultaneous Radiation in Locally Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Agennix, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Non-small Cell Lung, Lung Cancer |
| Intervention type | Drug |
| Interventions | Satraplatin |
| Enrollment | 20 |
| Start date | Aug 1, 2004 |
| Primary completion | Jan 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Oct 4, 2004 |
| Last update posted | Aug 17, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: